HolmesC.J.Peritoneal immune defense in continuous ambulatory peritoneal dialysis: Clinical relevance and practical implications.Perit Dial Int1993; 13(Suppl 2): S278–81.
2.
HolleyJ.L., BernardiniJ., PirainoB.Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritonealdialysisAmJKidneyDis1990; 16(2): 133–6.
3.
De FijterC.W.H., OeP.L., N autaJ.J.P.A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD). In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 7: 186–9.
4.
De FijterC.W.H., VerbrughH.A., OeL.P.Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.Kidney Int1992; 42: 947–50.
5.
GentileM.G., FellinG., RedaelliL.Multicenter study on peritonitis risk factors in CAPD. Report of the Italian CAPD Study Group. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. AdvanceS in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1986; 2: 138–40.
6.
SalomoneM., PiccoliG.B., BonelloF.Risk factors involved in peritonitis incidence: A multicenter regional experience. In: OtaK., MaherJ., WinchesterJ., HirszelP. eds. Current concepts in peritoneal dialysis.Amsterdam: Elseviers Science, 1992: 331–6.
7.
HoldenA.L., GaumerG.Best demonstrated practices program promoting CAPD patient retention in the United States. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1987; 3: 186–91.
8.
PortF.K., HeldP.J., NolphK.D.Risk of peritonitis and technique failure by CAPD connection technique: A national study.Kidney Int1992; 42: 967–74.
9.
TranaeusA., HeimburgerO., LindholmB.Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): Risk factors, clinical severity, and pathogenetic aspects.Perit Dial Int1988; 8: 253–63.
10.
LinbladA.S., NovakJ.W., NolphK.D.Continuous ambulatory peritoneal dialysis in the USA. Final report of the National CAPD Registry 1981–1988. Dordrecht: Kluwer Academic, 1989.
11.
FellinG., GentileM.G., CancariniG.Peritonitis in CAPD: Role of patients and staff. A report from the Italian CAPD Study Group. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1988; 4: 165–8.
12.
ViglinoG., GandolfoC., CottinoR.Can we obtain a further reduction of peritonitis episodes in CAPD patients already using a Y -set with disinfectant? In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6: 144–7.
13.
ViglinoG., CancariniG., CatizoneL.The impact of peritonitis on CAPD results. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 8: 269–75.
14.
HamburgerR.J., Mat ternW.D., SchreiberM.J.A dialysis modality decision guide based on the experience of six dialysis centers.Dialysis and Transplant1990; 19(2): 66–70.
15.
GroomeP.A., Hutchinson, PrichardS.S.ESRD treatment modality selection: Which factors are important in the decision? In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 7: 54–6.
KorbetS.M., VoneshE.F., FiranekC.A.A retrospective assessment of risk factors for peritonitis among an urban CAPD populationPeritDial Int1993; 13: 126–31.
18.
ZentR., MyersJ.E., DonaldD., RaynerB.L.Continuous ambulatory peritoneal dialysis: An option in the developing world?Perit Dial Int1994; 14: 48–51.
19.
ViglinoG., CancariniG.C., CatizoneL.Ten years experience of CAPD in diabetics: Comparison of results with non-diabetics.Nephrol Dial Transplant1994; 9: 1443–8.
20.
TranaeusA.Peritonitis in continuous peritoneal dialysis.Stockholm: Department of Renal Medicine, Karolinska Institute, Huddinge University Hospital, 1990.
21.
Canadian CAPD Clinical Trials Group.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems.Perit Dial Int1989; 9: 159–63.
22.
AbrahamG., SavinE., AyiomamitisA.Natural history of exit -site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1988; 8: 211–16.
23.
KeaneW.F., VasS.I.Peritonitis. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic, 1994: 473–501.
24.
TranaeusA., HeimburgerO., GranqvistS.Diverticular disease of the colon: A risk factor for peritonitis in continuous peritoneal dialysis.Nephrol Dial Transplant1990; 5: 141–7.
25.
LuzarM.A., ColesG.A., FallerB.Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.N Engl J Med1992; 322: 505–9.
26.
ZimmermanS.W., AhrensE., JohnsonC.A.Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.Am J Kidney Dis1991; 18(2): 225–31.
27.
BuoncristianiU., BianchiP., CozzariM.A new safe simple connection system for CAPD.Int J Nephrol Urol Androl1980; 1: 50.
28.
BazzatoG., LandiniS., ColiU.A new technique of continuous ambulatory peritoneal dialysis (CAPD): Double-bag system for freedom to the patient and significant reduction of peritonitis.Clin Nephrol1980; 13: 251.
29.
ViglinoG., ColomboA., ScalamognaA.Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1989; 9: 165–8.
ViglinoG., ColomboA., CantuP.In vitro and in vivo efficacy of a new connector device for continuous ambulatory peritoneal dialysis.Perit Dial Int1993; 13(Suppl 2): S148–51.
32.
BalteauP., PelusoF., ColesG.A.The Baxter integrated disconnected system (IDS), a clinical field trial.Perit Dial Int1991; 11: 131–6.
33.
OrangeG.V., HendersonI.S., MarshallE.A.Effectiveness of the flush technique in CAPD disconnect system.Int J ArtifOrgans1987; 10: 185.
34.
VergerC., LuzarM.A.In vitro study of CAPD Y-Iine systems. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1986; 2: 160–4.
35.
LuzarM.A., VergerC.In vitro evidence of reduction of touch contamination by the flush effect. In: GrabenseeB. ed. Reducing peritonitis and issues for today.Berlin: 1987: 15.
36.
LuzarM.A., SlingeneyerA., CantaluppiA., PelusoF.P.In vitro study of the flush effect in two reusable continuous ambulatory peritoneal dialysis (CAPD) disconnect systems.Perit Dial Int1989; 9: 169.
37.
MaiorcaR., CantaluppiA., CancariniG.C.Prospected controlled trial of a Y -connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis.Lancet1983; 2: 642.
38.
HeldP.J., PortF.K., GaylinD.S.Catheter-related factors and peritonitis risk in CAPD patients.Am J Kidney Dis1992; 20(Suppl 2): 48–54.
39.
TwardowskiZ.J., DobbieJ.W., MooreH.L.Morphology of peritoneal dialysis catheter tunnel: Macroscopy and light microscopy.Perit Dial Int1991; 11: 237–51.
40.
SmithC.CAPD: One cuff vs two cuff catheters in reference to incidence of infection. In: MaherJ.F., WinchesterJ.F. eds. Frontiers in peritoneal dialysis.New York: Field, Rich and Associates, 1986: 181–2.
41.
TwardowskiZ.J., ProwantB.F., KhannaR.Long term experience with Swan neck Missouri catheters.Trans Am Soc Artif Intern Organs1990; 36: M491–6.
42.
MoncriefJ.W., PopovichR.P., DasguptaM.Reduction in peritonitis incidence in continuous ambulatory peritoneal dialysis with a new catheter and implantation technique.Perit Dial Int1993; 13(Suppl 2): S329–31.
ProwantB.F., WaradyB.A., NolphK.D.Peritoneal dialysis catheter exit-site care: Results of an international survey.Perit Dial Int1993; 13: 149–54.
45.
PirainoB., BernardiniJ., SorkinM.I.The effect of the Y set on catheter infection rates in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1990; 16(1): 46–50.
46.
HolleyJ.L., BernardiniJ., PirainoB.Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set.Am J Kidney Dis1994; 23(4): 569–73.
47.
ColesG.A.Mupirocin study group. The effect of intranasal mupirocin on CAPD exit-site infection (ESI).J Am Soc Nephrol1994; 5(3): 439.
48.
MillikinS.P., MatzeG.R., KeaneW.F.Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.Perit Dial Int1991; 11: 252–60.
BernardiniJ., HolleyJ.L., JohnstonR.An analysis of ten-years trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD).Clin Nephrol1991; 36(1): 29–34.
51.
RobitailleP., MeerouaniA., ClermontM.J., EbertE.Successful antifungal prophylaxis in chronic peritoneal dialysis: A pediatric experience.Perit Dial Int1995; 15: 77–8.
52.
ZarubaK., PetersJ., JungbluthH.Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: Six years’ experience.Am J Kidney Dis1991; 17(1): 43–6.
53.
CairnsH.S., BeckettJ., RudgeC.J.Treatment of resistant CAPD peritonitis by temporary discontinuation of peritoneal dialysis.Clin Nephrol1989; 32(1): 27–30.
54.
ScalamognaA., CastelnovoC., De VecchiA., PonticelliC.Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1991; 18(6): 674–7.
55.
PirainoB., BernardiniJ., SorkinM.Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis.Am J Kidney Dis1989; 13(5): 365–9.
56.
Canadian Organ Replacement Register.1993 Annual Report.Don Mills, Ontario: Canadian Institute for Health Information, March, 1995.